Rivastigmine Transdermal Patch [General Sta­tis­tics]

posted by Lucas – Brazil, 2014-07-31 22:54 (4342 d 01:20 ago) – Posting: # 13329
Views: 11,668

Hello

❝ ...How on earth is table 11.4.8 to be interpreted?


The adhesion was evaluated at 9 time points during 24h for all subjects and the cummulative score was calculated, obtaining the CAS (Cummulative Adhesion Score) for each subject and treatment, which is the sum of all 9 scores.
We would have 9 evaluations for each period of each subject, each evaluation with a score from 0 to 4. Remember that the score will only increase from one time point to the next. These 9 scores would be cummulated to obtain the CAS. The values observed for CAS were 0 – 10 in this study. This table shows that, for instance, 22 of the 37 subjects had a CAS of 0 for the test treatment, meaning that the score for all the 9 time points of these subjects was 0.

But I just realised that I can't analyze the data without knowing the CAS for test and reference per subject. I was assuming that, for instance, the same subject who had a CAS of 10 for test had a CAS of 9 for reference, but I can't assume that. Very amateur mistake... :-(

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
148 visitors (0 registered, 148 guests [including 24 identified bots]).
Forum time: 00:15 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5